⌘K
Loading ticker…
VYNE Therapeutics Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, VYNE Therapeutics Inc. Common Stock (VYNE) has a 3-month relative strength percentile of 50 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.4%, relative volume 1.04×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
50 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
VYNE appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $158K notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $158K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VYNE Jan avg: 3.62% median: -14.51% win: 25% σ: 48.06% n: 4 2022-04-12 → 2026-05-29 | VYNE Feb avg: 3.74% median: 6.65% win: 75% σ: 24.38% n: 4 2022-04-12 → 2026-05-29 | VYNE Mar avg: -1.94% median: -4.06% win: 25% σ: 30.84% n: 4 2022-04-12 → 2026-05-29 | VYNE Apr avg: 3.98% median: -15.82% win: 40% σ: 39.07% n: 5 2022-04-12 → 2026-05-29 | VYNE May avg: -0.82% median: 0.79% win: 60% σ: 17.72% n: 5 2022-04-12 → 2026-05-29 | VYNE Jun avg: 2.97% median: -13.49% win: 25% σ: 48.75% n: 4 2022-04-12 → 2026-05-29 (current) | VYNE Jul avg: -14.22% median: 3.78% win: 50% σ: 43.08% n: 4 2022-04-12 → 2026-05-29 | VYNE Aug avg: -12.62% median: -9.39% win: 0% σ: 10.49% n: 4 2022-04-12 → 2026-05-29 | VYNE Sep avg: -7.02% median: -1.92% win: 50% σ: 15.42% n: 4 2022-04-12 → 2026-05-29 | VYNE Oct avg: 10.23% median: 10.37% win: 75% σ: 28.45% n: 4 2022-04-12 → 2026-05-29 | VYNE Nov avg: 4.17% median: 8.44% win: 75% σ: 8.78% n: 4 2022-04-12 → 2026-05-29 | VYNE Dec avg: -0.36% median: -8.22% win: 50% σ: 40.26% n: 4 2022-04-12 → 2026-05-29 |